Abstract
The first article in this issue's focus on government support of small and medium-sized biotechnology companies contains a critical overview of government support of SMEs in Canada. The author, a leading Canadian biotechnologist, surveys federal government initiatives and details the major initiatives. Canadian expenditure on R&D is unfavourably compared to that in other OECD countries. Although government support of biotechnology could be improved, the article points out improvements effected during the 1980s and looks forward to the 1990s.
Get full access to this article
View all access options for this article.